Cleared Traditional

K832871 - LIPASE HYDROLYSIS/GLYCEROL KINASE

K832871 is the FDA 510(k) clearance for LIPASE HYDROLYSIS/GLYCEROL KINASE by Pointe Scientific, Inc.,. It is a Class 1 Chemistry device (product code CDT) cleared through the Traditional 510(k) pathway after a 50-day FDA review.

K832871 · Pointe Scientific, Inc., · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1983
Decision
50d
Days
Class 1
Risk

K832871 is an FDA 510(k) clearance for the LIPASE HYDROLYSIS/GLYCEROL KINASE. Classified as Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides (product code CDT), Class I - General Controls.

Submitted by Pointe Scientific, Inc., (Mchenry, US). The FDA issued a Cleared decision on October 14, 1983 after a review of 50 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1705 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pointe Scientific, Inc., devices

Submission Details

510(k) Number K832871 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 25, 1983
Decision Date October 14, 1983
Days to Decision 50 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 88d · This submission: 50d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1705
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides

All 111
Devices cleared under the same product code (CDT) and FDA review panel - the closest regulatory comparables to K832871.
TRIGLYCERIDES REAGENT
K840780 · American Dade · Apr 1984
LIQUID STABLE TRIGLYCERIDES REAGENT SET
K834518 · Medical Analysis Systems, Inc. · Mar 1984
REAGENT SET TRIGLYCERIDES GPO
K833082 · Boehringer Mannheim Corp. · Nov 1983
SERALYZER TRIGLYCERIDES REAGENT STRIPS
K832684 · Miles Laboratories, Inc. · Oct 1983
ENZYMATIC TRIGLYCERIDES #2000
K832444 · Stanbio Laboratory · Aug 1983
TRIGLYCERIDES REAGENT SET
K831858 · Stanbio Laboratory · Jul 1983